< Back to latest news & events

Event

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

November 2021

Event date: 1st December 2021

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan’.

About the webinar

Digital transformation has been reshaping the pharmaceutical industry. Today, AI has helped explore novel uses of existing drugs, develop new drugs, and accelerate R&D activity in the industry.

In Japan, patent eligibility of AI-related inventions is less strict than that in EP practice. When AI has been applied to pharmaceuticals, issues on inventive step, support requirements, and enable requirements often arise as points to be overcome.

Our speakers will explain patent eligibility on combinations of AI and pharmaceutical inventions, suggesting some practical points of the JPO Examination Guidelines. They will then give listeners insight into some case examples of AI-related pharmaceutical patents in Japan.

Watch the webinar: 

Speakers

Dr. Masato Iida, Shiga

Fumio Takahashi, Shiga

Latest updates

Njoy v Juul finds the patent's underlying problem despite no mention of the problem in the specification

In Njoy v Juul (UPC CFI 315 /2023), the Paris Division of the Central Division provides further insight into the UPC’s approach to inventive step. Of critical importance in assessing …

Read article

The IP Lawyer’s Cheat Sheet: Lucy Johnson on Innovation, Legislation, and Strategy

The world of intellectual property is on the brink of significant transformation. From navigating the use of AI technology to staying ahead of increasingly sophisticated bad actors, IP professionals must …

Read article

Edwards v Meril confirms UPC’s jurisdiction over acts of infringement before the court came into force

In Edwards v Meril (UPC_CGI_15/2023), the UPC’s Munich local division refused to stay infringement proceedings pending an appeal on the central division’s finding of validity of the patent in amended …

Read article

Success of the Gilette Defence fizzles out in SodaStream v Aarke

In SodaStream v Aarke (UPC_CFI_373/2023), the UPC’s Dusseldorf local division has given us further insight into the UPC’s approach to claim interpretation. The court held that, if the patent distinguishes …

Read article

IP Ingredients: How the trademark landscape is adapting to the NoLo trend

Beverage producer and brand owner? This article may be for you, as changes in how EU trademark authorities compare alcoholic and non-alcoholic products make it easier for brand owners to …

Read article

HGF ranked as a top tier firm in Legal 500 UK 2025

HGF has been recommended as a top-tier firm in UK PATMA Trade Mark Attorneys – Tier 1. We also continue to be highly ranked in Tier 2 in the regions …

Read article
Event - 18th November 2024

Innovate Oxford: Healthcare Investor Networking Reception

HGF are proud to be attending the Innovate Oxford: Healthcare Investor Networking Reception in London. The Networking Reception will be held at the National Theatre, Southbank, London on 18th November. …

Event details
See all updates